A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Clinical trial NCT05850364 · COMPLETED

Trial details

NCT number: NCT05850364
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Poliomyelitis Polio

Start date: 2023-05-22
Primary completion: 2025-02-13
Enrollment: 1442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.